IIT researchers to re-purpose approved drugs from DrugBank database for treating COVID-19 by targeting SARS-CoV-2 main protease
Taking advantage of available crystal structure of the SARS-CoV-2 main protease, a structure-based inhibitor design will be done by the researchers from the available FDA approved drugs compounds in the DrugBank database.
Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid-19 patients
Nafamostat has been identified as a potential candidate for Covid-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate Research, Germany
CCMB researchers culture novel coronavirus; research may help in drug testing and vaccine development
Virologists at CCMB have isolated infectious viruses from several isolates. The ability to culture the virus in lab enables CCMB to work towards vaccine development.